ESPE Abstracts (2016) 86 P-P2-93

Use of an F-DEX Monocyte Binding Assay to Measure Steroid Responsiveness of Patients and their Related Donors Undergoing Stem Cell Transplant

Alfred Gillio, Jennifer Krajewski, Michele Donato, Scott Rowley, Javier Aisenberg & Steven Ghanny

Hackensack University Medical Center, Hackensack, New Jersey, USA

Background: Graft versus host disease (GVHD) is a complex disease resulting from donor T-cell recognition of a genetic disparate recipient, which is unable to reject donor cells after allogeneic transplant. Glucocorticoids (steroids) are the mainstay of acute GVHD therapy. Glucocorticoid resistance has been characterized in several inflammatory conditions including asthma, rheumatoid arthritis, systemic lupus, erythematosus, ulcerative colitis, and Crohn’s disease. Glucocorticoid resistance has also been seen in a subset of patients with GVHD. However, to date, the biology of this steroid refractoriness in the treatment of GVHD has not been examined.

Objective and hypotheses: We propose to study the steroid sensitivity of bone marrow transplanted patients and their related donors using a Fluorescein labelled dexamethasone (F-DEX) monocyte binding assay to help in the treatment of these patients.

Method: Collection of pre- and post-BMT blood samples from 20 patient/donor pairs who plan to undergo allogeneic bone marrow transplant. The samples will be analysed using a F-DEX monocyte binding assay of collected monocytes.

Results: Currently preliminary results are being ascertained.

Conclusion: We hope that the data collected from these patients will help to examine steroid sensitivity in these patients and help to design better treatment strategies for these patients.

Article tools

My recent searches

No recent searches.